Dot1L-IN-1 TFA (C09-1126-747)

Dot1L-IN-1 TFA is a highly potent and selective Dot1L inhibitor with a K i of 2 pM and an IC 50 of <0.1 nM. Dot1L-IN-1 TFA potently suppresses H3K79 dimethylation (IC 50 =3 nM), as well as the activity of the HoxA9 promoter (IC 50 =17 nM) in HeLa and MolmAppearance:SolidIC50& Target:DOT1LIn Vitro:Dot1L-IN-1 (analogue 7) TFA effectively inhibits proliferation of the human MLL-rearranged leukemia cell line MV4-11 carrying the oncogenic MLL-AF4 fusion (IC 50 =5 nM). MCE has not independently confirmed the accuracy of these methods. They are forBiological Activity:Dot1L-IN-1 TFA is a highly potent and selective Dot1L inhibitor with a K i of 2 pM and an IC 50 of <0.1 nM. Dot1L-IN-1 TFA potently suppresses H3K79 dimethylation (IC 50 =3 nM), as well as the activity of the HoxA9 promoter (IC 50 =17 nM) in HeLa and Molm. Specification: 0.98 Molecular Formula: C34H37ClF3N9O4S Molecular Weight: 760.23